Please Wait.....
Report
Histology and Cytology Market By Type of Examination (Histology, Cytology), By Product (Instruments and Analysis Software System, Consumable and Reagents), By Test Type (Microscopy Methods, Flow Cytometry, Molecular Genetic Methods), By Application (Drug Discovery and Designing, Clinical Diagnostics, Academic Research), By End User (Pharma and Biotech Companies, CDMO, Diagnostic Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2024-02-01 I 298 Pages I Allied Market Research
The global histology and cytology market was valued at $7.2 billion in 2022, and is projected to reach $22.2 billion by 2032, growing at a CAGR of 11.9% from 2023 to 2032.
Histology and cytology constitute indispensable analytical techniques in the healthcare sector, holding a pivotal significance in the diagnosis and therapeutic management of diverse medical conditions. Histology entails the microscopic examination of tissues, scrutinizing their structural characteristics and identifying anomalies, whereas cytology concentrates on the examination of individual cells to identify abnormalities or diseases. These diagnostic methodologies play a critical role in the timely identification of cancer, infectious diseases, and other pathological conditions.
The rise in prevalence of chronic diseases such as cancer and the improving healthcare infrastructure is expected to drive the growth of the histology and cytology market. For instance, according to the American Cancer Society, it was reported that in 2020, Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. The notable increase in chronic conditions, such as cancer, cardiovascular diseases, and respiratory disorders, has created a pressing need for advanced diagnostic and screening methods.
Histology and cytology procedures provide invaluable insights into the cellular and tissue-level changes associated with malignancies, aiding in accurate diagnosis and the formulation of personalized treatment strategies. Moreover, as the aging population continues to grow worldwide, there is an inherent increase in the incidence of chronic diseases, further driving the demand for histology and cytology for disease diagnosis.
In addition, surge in awareness among healthcare professionals and patients plays a crucial role in driving the demand for histological and cytological examinations, as individuals become more proactive in managing their health and seeking early detection of diseases. Patients increasingly recognize the importance of histology and cytology in diagnosing various medical conditions, including cancers and infectious diseases, which has led to a rising demand for these diagnostic technologies. Moreover, healthcare professionals have become more aware of the benefits of histology and cytology in providing accurate and timely diagnoses. With advancements in medical research and technology, healthcare professionals are better equipped to understand the significance of these diagnostic tools and incorporate them into their clinical practices. Thus, the rise in awareness among the healthcare professionals and patients is expected to drive the growth of the market.
Furthermore, the improving healthcare infrastructure in developing countries is expected to drive the growth of the market. As countries across the developing regions progressively invest in upgrading their healthcare systems, there is a surge in demand for advanced diagnostic techniques, such as histology and cytology, which play a crucial role in disease detection and management.For instance, according to the 2023 report by National Library of Medicine, it was reported that over two lakh public health facilities were reported in India as of the financial year 2022. The expansion and modernization of healthcare facilities, including hospitals, diagnostic laboratories, and research centers, are creating a robust ecosystem for the adoption of cutting-edge histology and cytology technologies. Thus, the improving healthcare infrastructure is expected to significantly contribute to the growth of the market.
?
The histology and cytology market is segmented on the basis of type of examination, product, test type, application, end user, and region. On the basis of type of examination, the market is bifurcated into histology and cytology. On the basis of product, the market is classified into instruments and analysis software system and consumable and reagents. On the basis of test type, the market is divided into microscopy methods, flow cytometry, and molecular genetic methods.
On the basis of application, the market is segregated into drug discovery and designing, clinical diagnostics, and academic research. On the basis of end user, the market is fragmented into pharma & biotech companies, CDMO, diagnostic laboratories, and others. Others include hospital and academic research. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Major key players that operate in the histology and cytology market are Hologic, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., Sysmex Corporation, Trivitron Healthcare Private Limited, and Koninklijke Philips N.V.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the histology and cytology market analysis from 2022 to 2032 to identify the prevailing histology and cytology market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the histology and cytology market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global histology and cytology market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Type of Examination
- Histology
- Cytology
By Product
- Instruments and Analysis Software System
- Consumable and Reagents
By Test Type
- Microscopy Methods
- Flow Cytometry
- Molecular Genetic Methods
By Application
- Drug Discovery and Designing
- Clinical Diagnostics
- Academic Research
By End User
- Pharma and Biotech Companies
- CDMO
- Diagnostic Laboratories
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Colombia
- Argentina
- Rest of Latin America
- Middle East and Africa
- Gcc
- South Africa
- North Africa
- Rest Of Mea
- Key Market Players
- Abbott Laboratories
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Trivitron Healthcare Private Limited
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Sysmex Corporation
- Becton, Dickinson, and Company
- Hologic, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growing Pharmaceutical Industry in Asia Pacific Region.
3.4.1.2. Surge in prevalence of chronic diseases.
3.4.1.3. Improving Healthcare Infrastructure.
3.4.2. Restraints
3.4.2.1. High cost of histological and cytological analytical instruments.
3.4.3. Opportunities
3.4.3.1. Technological advancement in the histological and cytological analysis technology.
CHAPTER 4: HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Histology
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Cytology
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Instruments and Analysis Software System
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Consumable and Reagents
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Microscopy Methods
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Flow Cytometry
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Molecular Genetic Methods
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION
7.1. Overview
7.1.1. Market size and forecast
7.2. Drug Discovery and Designing
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Clinical Diagnostics
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic Research
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: HISTOLOGY AND CYTOLOGY MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Pharma and Biotech Companies
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market share analysis by country
8.3. CDMO
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market share analysis by country
8.4. Diagnostic Laboratories
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by region
8.4.3. Market share analysis by country
8.5. Others
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by region
8.5.3. Market share analysis by country
CHAPTER 9: HISTOLOGY AND CYTOLOGY MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast By Region
9.2. North America
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast, by Type of Examination
9.2.3. Market size and forecast, by Product
9.2.4. Market size and forecast, by Test Type
9.2.5. Market size and forecast, by Application
9.2.6. Market size and forecast, by End User
9.2.7. Market size and forecast, by country
9.2.7.1. U.S.
9.2.7.1.1. Market size and forecast, by Type of Examination
9.2.7.1.2. Market size and forecast, by Product
9.2.7.1.3. Market size and forecast, by Test Type
9.2.7.1.4. Market size and forecast, by Application
9.2.7.1.5. Market size and forecast, by End User
9.2.7.2. Canada
9.2.7.2.1. Market size and forecast, by Type of Examination
9.2.7.2.2. Market size and forecast, by Product
9.2.7.2.3. Market size and forecast, by Test Type
9.2.7.2.4. Market size and forecast, by Application
9.2.7.2.5. Market size and forecast, by End User
9.2.7.3. Mexico
9.2.7.3.1. Market size and forecast, by Type of Examination
9.2.7.3.2. Market size and forecast, by Product
9.2.7.3.3. Market size and forecast, by Test Type
9.2.7.3.4. Market size and forecast, by Application
9.2.7.3.5. Market size and forecast, by End User
9.3. Europe
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast, by Type of Examination
9.3.3. Market size and forecast, by Product
9.3.4. Market size and forecast, by Test Type
9.3.5. Market size and forecast, by Application
9.3.6. Market size and forecast, by End User
9.3.7. Market size and forecast, by country
9.3.7.1. Germany
9.3.7.1.1. Market size and forecast, by Type of Examination
9.3.7.1.2. Market size and forecast, by Product
9.3.7.1.3. Market size and forecast, by Test Type
9.3.7.1.4. Market size and forecast, by Application
9.3.7.1.5. Market size and forecast, by End User
9.3.7.2. France
9.3.7.2.1. Market size and forecast, by Type of Examination
9.3.7.2.2. Market size and forecast, by Product
9.3.7.2.3. Market size and forecast, by Test Type
9.3.7.2.4. Market size and forecast, by Application
9.3.7.2.5. Market size and forecast, by End User
9.3.7.3. UK
9.3.7.3.1. Market size and forecast, by Type of Examination
9.3.7.3.2. Market size and forecast, by Product
9.3.7.3.3. Market size and forecast, by Test Type
9.3.7.3.4. Market size and forecast, by Application
9.3.7.3.5. Market size and forecast, by End User
9.3.7.4. Italy
9.3.7.4.1. Market size and forecast, by Type of Examination
9.3.7.4.2. Market size and forecast, by Product
9.3.7.4.3. Market size and forecast, by Test Type
9.3.7.4.4. Market size and forecast, by Application
9.3.7.4.5. Market size and forecast, by End User
9.3.7.5. Spain
9.3.7.5.1. Market size and forecast, by Type of Examination
9.3.7.5.2. Market size and forecast, by Product
9.3.7.5.3. Market size and forecast, by Test Type
9.3.7.5.4. Market size and forecast, by Application
9.3.7.5.5. Market size and forecast, by End User
9.3.7.6. Rest of Europe
9.3.7.6.1. Market size and forecast, by Type of Examination
9.3.7.6.2. Market size and forecast, by Product
9.3.7.6.3. Market size and forecast, by Test Type
9.3.7.6.4. Market size and forecast, by Application
9.3.7.6.5. Market size and forecast, by End User
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast, by Type of Examination
9.4.3. Market size and forecast, by Product
9.4.4. Market size and forecast, by Test Type
9.4.5. Market size and forecast, by Application
9.4.6. Market size and forecast, by End User
9.4.7. Market size and forecast, by country
9.4.7.1. Japan
9.4.7.1.1. Market size and forecast, by Type of Examination
9.4.7.1.2. Market size and forecast, by Product
9.4.7.1.3. Market size and forecast, by Test Type
9.4.7.1.4. Market size and forecast, by Application
9.4.7.1.5. Market size and forecast, by End User
9.4.7.2. China
9.4.7.2.1. Market size and forecast, by Type of Examination
9.4.7.2.2. Market size and forecast, by Product
9.4.7.2.3. Market size and forecast, by Test Type
9.4.7.2.4. Market size and forecast, by Application
9.4.7.2.5. Market size and forecast, by End User
9.4.7.3. India
9.4.7.3.1. Market size and forecast, by Type of Examination
9.4.7.3.2. Market size and forecast, by Product
9.4.7.3.3. Market size and forecast, by Test Type
9.4.7.3.4. Market size and forecast, by Application
9.4.7.3.5. Market size and forecast, by End User
9.4.7.4. Australia
9.4.7.4.1. Market size and forecast, by Type of Examination
9.4.7.4.2. Market size and forecast, by Product
9.4.7.4.3. Market size and forecast, by Test Type
9.4.7.4.4. Market size and forecast, by Application
9.4.7.4.5. Market size and forecast, by End User
9.4.7.5. South Korea
9.4.7.5.1. Market size and forecast, by Type of Examination
9.4.7.5.2. Market size and forecast, by Product
9.4.7.5.3. Market size and forecast, by Test Type
9.4.7.5.4. Market size and forecast, by Application
9.4.7.5.5. Market size and forecast, by End User
9.4.7.6. Rest of Asia-Pacific
9.4.7.6.1. Market size and forecast, by Type of Examination
9.4.7.6.2. Market size and forecast, by Product
9.4.7.6.3. Market size and forecast, by Test Type
9.4.7.6.4. Market size and forecast, by Application
9.4.7.6.5. Market size and forecast, by End User
9.5. Latin America
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast, by Type of Examination
9.5.3. Market size and forecast, by Product
9.5.4. Market size and forecast, by Test Type
9.5.5. Market size and forecast, by Application
9.5.6. Market size and forecast, by End User
9.5.7. Market size and forecast, by country
9.5.7.1. Brazil
9.5.7.1.1. Market size and forecast, by Type of Examination
9.5.7.1.2. Market size and forecast, by Product
9.5.7.1.3. Market size and forecast, by Test Type
9.5.7.1.4. Market size and forecast, by Application
9.5.7.1.5. Market size and forecast, by End User
9.5.7.2. Colombia
9.5.7.2.1. Market size and forecast, by Type of Examination
9.5.7.2.2. Market size and forecast, by Product
9.5.7.2.3. Market size and forecast, by Test Type
9.5.7.2.4. Market size and forecast, by Application
9.5.7.2.5. Market size and forecast, by End User
9.5.7.3. Argentina
9.5.7.3.1. Market size and forecast, by Type of Examination
9.5.7.3.2. Market size and forecast, by Product
9.5.7.3.3. Market size and forecast, by Test Type
9.5.7.3.4. Market size and forecast, by Application
9.5.7.3.5. Market size and forecast, by End User
9.5.7.4. Rest of Latin America
9.5.7.4.1. Market size and forecast, by Type of Examination
9.5.7.4.2. Market size and forecast, by Product
9.5.7.4.3. Market size and forecast, by Test Type
9.5.7.4.4. Market size and forecast, by Application
9.5.7.4.5. Market size and forecast, by End User
9.6. Middle East and Africa
9.6.1. Key market trends, growth factors and opportunities
9.6.2. Market size and forecast, by Type of Examination
9.6.3. Market size and forecast, by Product
9.6.4. Market size and forecast, by Test Type
9.6.5. Market size and forecast, by Application
9.6.6. Market size and forecast, by End User
9.6.7. Market size and forecast, by country
9.6.7.1. Gcc
9.6.7.1.1. Market size and forecast, by Type of Examination
9.6.7.1.2. Market size and forecast, by Product
9.6.7.1.3. Market size and forecast, by Test Type
9.6.7.1.4. Market size and forecast, by Application
9.6.7.1.5. Market size and forecast, by End User
9.6.7.2. South Africa
9.6.7.2.1. Market size and forecast, by Type of Examination
9.6.7.2.2. Market size and forecast, by Product
9.6.7.2.3. Market size and forecast, by Test Type
9.6.7.2.4. Market size and forecast, by Application
9.6.7.2.5. Market size and forecast, by End User
9.6.7.3. North Africa
9.6.7.3.1. Market size and forecast, by Type of Examination
9.6.7.3.2. Market size and forecast, by Product
9.6.7.3.3. Market size and forecast, by Test Type
9.6.7.3.4. Market size and forecast, by Application
9.6.7.3.5. Market size and forecast, by End User
9.6.7.4. Rest Of Mea
9.6.7.4.1. Market size and forecast, by Type of Examination
9.6.7.4.2. Market size and forecast, by Product
9.6.7.4.3. Market size and forecast, by Test Type
9.6.7.4.4. Market size and forecast, by Application
9.6.7.4.5. Market size and forecast, by End User
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022
CHAPTER 11: COMPANY PROFILES
11.1. Hologic, Inc.
11.1.1. Company overview
11.1.2. Key executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. Business performance
11.2. F. Hoffmann-La Roche Ltd.
11.2.1. Company overview
11.2.2. Key executives
11.2.3. Company snapshot
11.2.4. Operating business segments
11.2.5. Product portfolio
11.2.6. Business performance
11.2.7. Key strategic moves and developments
11.3. Abbott Laboratories
11.3.1. Company overview
11.3.2. Key executives
11.3.3. Company snapshot
11.3.4. Operating business segments
11.3.5. Product portfolio
11.3.6. Business performance
11.4. Becton, Dickinson, and Company
11.4.1. Company overview
11.4.2. Key executives
11.4.3. Company snapshot
11.4.4. Operating business segments
11.4.5. Product portfolio
11.4.6. Business performance
11.4.7. Key strategic moves and developments
11.5. Danaher Corporation
11.5.1. Company overview
11.5.2. Key executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.5.6. Business performance
11.6. Merck KGaA
11.6.1. Company overview
11.6.2. Key executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.6.6. Business performance
11.7. Thermo Fisher Scientific, Inc.
11.7.1. Company overview
11.7.2. Key executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. Business performance
11.8. Sysmex Corporation
11.8.1. Company overview
11.8.2. Key executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.8.6. Business performance
11.9. Trivitron Healthcare Private Limited
11.9.1. Company overview
11.9.2. Key executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.10. Koninklijke Philips N.V.
11.10.1. Company overview
11.10.2. Key executives
11.10.3. Company snapshot
11.10.4. Operating business segments
11.10.5. Product portfolio
11.10.6. Business performance
LIST OF TABLES
TABLE 01. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 02. HISTOLOGY AND CYTOLOGY MARKET FOR HISTOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 03. HISTOLOGY AND CYTOLOGY MARKET FOR CYTOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 05. HISTOLOGY AND CYTOLOGY MARKET FOR INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, BY REGION, 2022-2032 ($MILLION)
TABLE 06. HISTOLOGY AND CYTOLOGY MARKET FOR CONSUMABLE AND REAGENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 08. HISTOLOGY AND CYTOLOGY MARKET FOR MICROSCOPY METHODS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. HISTOLOGY AND CYTOLOGY MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 10. HISTOLOGY AND CYTOLOGY MARKET FOR MOLECULAR GENETIC METHODS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 12. HISTOLOGY AND CYTOLOGY MARKET FOR DRUG DISCOVERY AND DESIGNING, BY REGION, 2022-2032 ($MILLION)
TABLE 13. HISTOLOGY AND CYTOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. HISTOLOGY AND CYTOLOGY MARKET FOR ACADEMIC RESEARCH, BY REGION, 2022-2032 ($MILLION)
TABLE 15. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. HISTOLOGY AND CYTOLOGY MARKET FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 17. HISTOLOGY AND CYTOLOGY MARKET FOR CDMO, BY REGION, 2022-2032 ($MILLION)
TABLE 18. HISTOLOGY AND CYTOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 19. HISTOLOGY AND CYTOLOGY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 20. HISTOLOGY AND CYTOLOGY MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 21. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 22. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 24. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 27. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 28. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 29. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 30. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 31. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 33. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 34. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 35. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 38. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 39. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 40. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 43. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 45. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 47. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 48. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 49. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 51. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 52. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 53. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 54. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 55. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 56. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 57. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. UK HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 59. UK HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. UK HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 61. UK HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. UK HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 63. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 64. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 65. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 66. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 68. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 69. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 70. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 71. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 74. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 75. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 76. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 77. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 79. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 80. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 81. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 82. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 84. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 85. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 86. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 87. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 88. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 90. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 91. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 92. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 93. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 94. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 95. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 96. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 97. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 98. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 99. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 100. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 101. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 102. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 103. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 105. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 106. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 107. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 108. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 109. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 110. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 111. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 112. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 113. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 114. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 115. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 116. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 117. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 118. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 119. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 120. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 121. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 122. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 123. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 124. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 125. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 126. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 127. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 128. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 129. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 130. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 131. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 132. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 133. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 134. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 135. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 136. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 137. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 138. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 139. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 140. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 141. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 142. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 143. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 144. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 145. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 146. GCC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 147. GCC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 148. GCC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 149. GCC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 150. GCC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 151. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 152. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 153. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 154. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 155. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 156. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 157. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 158. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 159. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 160. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 161. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
TABLE 162. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 163. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
TABLE 164. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 165. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 166. HOLOGIC, INC.: KEY EXECUTIVES
TABLE 167. HOLOGIC, INC.: COMPANY SNAPSHOT
TABLE 168. HOLOGIC, INC.: PRODUCT SEGMENTS
TABLE 169. HOLOGIC, INC.: PRODUCT PORTFOLIO
TABLE 170. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 171. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 172. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 173. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 174. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
TABLE 175. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 176. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 177. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 178. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 179. BECTON, DICKINSON, AND COMPANY: KEY EXECUTIVES
TABLE 180. BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT
TABLE 181. BECTON, DICKINSON, AND COMPANY: PRODUCT SEGMENTS
TABLE 182. BECTON, DICKINSON, AND COMPANY: PRODUCT PORTFOLIO
TABLE 183. BECTON, DICKINSON, AND COMPANY: KEY STRATERGIES
TABLE 184. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 185. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 186. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 187. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 188. MERCK KGAA: KEY EXECUTIVES
TABLE 189. MERCK KGAA: COMPANY SNAPSHOT
TABLE 190. MERCK KGAA: PRODUCT SEGMENTS
TABLE 191. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 192. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 193. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 194. THERMO FISHER SCIENTIFIC, INC.: PRODUCT SEGMENTS
TABLE 195. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 196. SYSMEX CORPORATION: KEY EXECUTIVES
TABLE 197. SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 198. SYSMEX CORPORATION: PRODUCT SEGMENTS
TABLE 199. SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 200. TRIVITRON HEALTHCARE PRIVATE LIMITED: KEY EXECUTIVES
TABLE 201. TRIVITRON HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT
TABLE 202. TRIVITRON HEALTHCARE PRIVATE LIMITED: PRODUCT SEGMENTS
TABLE 203. TRIVITRON HEALTHCARE PRIVATE LIMITED: PRODUCT PORTFOLIO
TABLE 204. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 205. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 206. KONINKLIJKE PHILIPS N.V.: SERVICE SEGMENTS
TABLE 207. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. HISTOLOGY AND CYTOLOGY MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF HISTOLOGY AND CYTOLOGY MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN HISTOLOGY AND CYTOLOGY MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN HISTOLOGY AND CYTOLOGY MARKET (2023-2032)
FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTES
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. LOW BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL HISTOLOGY AND CYTOLOGY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR HISTOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CYTOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CONSUMABLE AND REAGENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR MICROSCOPY METHODS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR MOLECULAR GENETIC METHODS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR DRUG DISCOVERY AND DESIGNING, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR ACADEMIC RESEARCH, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR PHARMA AND BIOTECH COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CDMO, BY COUNTRY 2022 AND 2032(%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 30. HISTOLOGY AND CYTOLOGY MARKET BY REGION, 2022 AND 2032(%)
FIGURE 31. U.S. HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 32. CANADA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 33. MEXICO HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 34. GERMANY HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 35. FRANCE HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 36. UK HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 37. ITALY HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 38. SPAIN HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 39. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 40. JAPAN HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 41. CHINA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 42. INDIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 43. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 44. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 45. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 46. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 47. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 48. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 49. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 50. GCC HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 51. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 52. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 53. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
FIGURE 54. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
FIGURE 55. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
FIGURE 56. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
FIGURE 57. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 58. COMPETITIVE DASHBOARD
FIGURE 59. COMPETITIVE HEATMAP: HISTOLOGY AND CYTOLOGY MARKET
FIGURE 60. TOP PLAYER POSITIONING, 2022
FIGURE 61. HOLOGIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 62. HOLOGIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. HOLOGIC, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
FIGURE 65. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 66. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 67. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 68. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 69. BECTON, DICKINSON, AND COMPANY: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 70. BECTON, DICKINSON, AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 71. BECTON, DICKINSON, AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 72. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 73. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 74. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 75. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
FIGURE 76. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 77. MERCK KGAA: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 78. THERMO FISHER SCIENTIFIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 79. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 80. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 81. SYSMEX CORPORATION: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 82. SYSMEX CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 83. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
FIGURE 84. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 85. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security